Sign in
Taking people in United StatesNo phase

Glucagon Response in Young Adults with Type 1 Diabetes on Low-Carb Diet

Tests glucagon response in young adults with type 1 diabetes on a low-carb diet.

Key facts

Who runs it
Boston Children's Hospital
Where
Boston, United StatesSee the site
Trial code
Registry title
Very Low Carbohydrate Diets and Glucagon Response in T1DM
Status
Recruiting
People taking part
12 people, planned
Started
3 Jan 2020
Planned end
31 Jul 2026
Type of study
Interventional
Treatments tested
  • Very low carbohydrate diet
Record updated
18 December 2024

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for young adults aged 18 to 40 with type 1 diabetes who use an insulin pump and a continuous glucose monitor.

Age
18 to 40 years
Sex
Men and women
Disease stage
Type 1 diabetes for at least 1 year, with stable blood sugar control (HbA1c 6.5-9% (48–75 mmol/mol)). Tanner stage IV or higher. BMI 18.5-35 kg/m2.
Earlier treatment
Must use an insulin pump and a continuous glucose monitor (CGM). Must have attended at least 1 diabetes care visit in the past 12 months. Must not be on a weight-loss or other restrictive diet.
Biomarker or test result
HbA1c 6.5-9% (48–75 mmol/mol)

Main reasons for not taking part

  • Ketoacidosis or severe low blood sugar with seizure or coma in the past 6 months
  • Pregnancy or breastfeeding
  • History of an eating disorder or at risk for one
  • Smoking, recreational drugs or excessive alcohol
  • Major medical illness, significant psychiatric illness, or anemia

The registry criteria, word for word

Show all 19 criteriaShow less

Who can take part

  • Males and females with T1D for at least 1 year
  • Age 18 to 40 years
  • Tanner stage ≥ IV
  • BMI 18.5-35 kg/m2
  • Stable glycemic control (HbA1c 6.5-9%)
  • Use of a continuous glucose monitor (CGM)
  • Use of an insulin pump
  • Attendance of at least 1 diabetes care visit over the past 12 months (including virtual)

Who cannot take part

  • Smoking, use of recreational drugs, or excessive alcohol consumption
  • For participants who undergo MRI:; Standard MRI exclusion criteria; Irregular menses; Use of psychotropic medication other than SSRIs or other mild antidepressant or anxiety medications (unless these medications are safe to be held for several days to allow for the acquisition of MRI data)
  • Ketoacidosis or severe hypoglycemia with seizure or coma in the past 6 months
  • Dietary restrictions or intolerances that are incompatible with the planned food deliveries, e.g. celiac disease, gastroparesis, certain food allergies
  • History of an eating disorder or at risk for eating disorder, assessed by the Eating Disorders Diagnostic Scale (EDDS)
  • Major medical illness or use of medications other than insulin and metformin that could interfere with metabolic or glycemic variables
  • Significant psychiatric illness
  • Following a weight-loss or otherwise restrictive diet
  • Vigorous exercise >2 hours on >3 days a week
  • Pregnancy or breastfeeding
  • Anemia

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 40 years old?

Where in United States

  • Boston Children's HospitalBoston, United StatesContact: Belinda S LennerzTaking people

About the trial

What the trial wants to find out

Despite major technological advances, management of type one diabetes mellitus (T1D) remains suboptimal, putting millions of people at risk for immediate and long-term complications. After meals, a mismatch between carbohydrate absorption rate and insulin action typically leads to alternating periods of hyper- and hypoglycemia. A conceptually promising approach to control both problems is dietary carbohydrate restriction to reduce postprandial blood glucose changes and insulin needs. In a prior survey study, the investigators documented exceptional glycemic control (HbA1c 5.67%) and low acute complication rates among 316 children and adults with T1D consuming a very-low-carbohydrate (VLC) diet. Despite these promising preliminary results, the use of VLC diets for T1D remain controversial, because of their restrictive nature and theoretical concerns regarding growth, ketoacidosis and hypoglycemia risks and efficiency of glucagon treatment for hypoglycemia. Glucagon is used as a rescue medication during severe hypoglycemia and increases blood glucose levels by mobilizing liver glycogen stores. If these stores are depleted during carbohydrate restriction, glucagon response may be inadequate and put individuals at risk for refractory hypoglycemia. A physiologic study has shown a blunted but still adequate response to glucagon in n=10 participants after following a VLCD for 1 week. Longer-term studies have not been done.

Read full original descriptionShow less

To test the hypotheses that glucagon response remains adequate while following a VLC diet in the longer term, the investigators will conduct a glucagon challenge in participants who are assigned to the VLC arm of a randomized-controlled feeding study in 32 young adults with T1D who will receive a VLC vs a standard diet for 12 weeks. After an overnight fast, twelve participants in the VLC arm will receive IV insulin to lower blood glucose levels to 60 mg/dL, followed by a glucagon injection and monitoring of blood glucose levels and other metabolic fuels.

The group in the trial

  • Very low carbohydrate dietTreatment being tested

    Dietary Intervention, food delivery

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Glucagon Response in Patients With Type 1 Diabetes Mellitus Following a Very Low Carbohydrate
Plain-language title
Glucagon Response in Young Adults with Type 1 Diabetes on Low-Carb DietGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Fit questions
Built from NCT04200391, who can take part
Record updated
18 December 2024